# Sunniside Healthcare Limited

## Details

- **Company number:** [07593597](https://find-and-update.company-information.service.gov.uk/company/07593597)
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 6 Apr 2011
- **Registered office:** 9 DEWHURST TERRACE, SUNNISIDE, NEWCASTLE UPON TYNE, NE16 5LP
- **Nature of business:** [46460](/sic/46460) Wholesale of pharmaceutical goods
- **Corporate group:** [Arden Healthcare Group Limited](/group/41949) (2 companies)


## Previous names

- M.R. Crowder Ltd (until 3 Oct 2018)




## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Mr Malcolm Ralph Crowder | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 6 Apr 2016 | 2 Aug 2017 |
| Mrs Ann Crowder | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 6 Apr 2016 | 2 Aug 2017 |
| Mr David Graham Jarvis | ownership-of-shares-50-to-75-percent | 2 Aug 2017 | 13 Apr 2022 |
| Edenhill Healthcare Limited | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent | 2 Aug 2017 | 7 Aug 2024 |
| Arden Healthcare Group Limited | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent | 7 Aug 2024 |  |



## Accounts

| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Jul 2025 | £662,980 | £33,261 | 0 |
| 7 Aug 2024 | £659,619 | £3,944 | 0 |
| 31 Aug 2023 | £648,009 | £21,834 | 11 |
| 31 Aug 2022 | £682,266 | £53,045 | 11 |
| 31 Aug 2021 | £651,388 | £48,806 | 10 |
| 31 Aug 2020 | £584,765 | £107,098 | 9 |
| 31 Aug 2019 | £535,393 | £65,176 | 7 |
| 31 Aug 2018 | £528,243 | £61,922 | 8 |
| 31 Jul 2017 | - | £108,719 | 9 |
| 31 May 2016 | - | £96,349 | - |
| 31 May 2015 | - | £66,967 | - |
| 31 May 2014 | - | £87,584 | - |
| 31 May 2013 | - | £61,664 | - |
| 31 May 2012 | £570,318 | £45,800 | - |



## Owned by

Sunniside Healthcare Limited → [Arden Healthcare Group Limited](/company/15579004)





## Companies at the same address

- [Arden Healthcare Group Limited](/company/15579004) (15579004)



